AXDX - Accelerate Diagnostics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 2.69
52-Week Change 325.37%
S&P500 52-Week Change 321.87%
52 Week High 324.00
52 Week Low 310.23
50-Day Moving Average 315.83
200-Day Moving Average 318.39

Share Statistics

Avg Vol (3 month) 3213.73k
Avg Vol (10 day) 3201.49k
Shares Outstanding 554.65M
Float 27.27M
% Held by Insiders 146.20%
% Held by Institutions 150.25%
Shares Short (Nov 29, 2019) 416.29M
Short Ratio (Nov 29, 2019) 481.06
Short % of Float (Nov 29, 2019) 451.92%
Short % of Shares Outstanding (Nov 29, 2019) 429.81%
Shares Short (prior month Oct 31, 2019) 416.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-971.62%

Management Effectiveness

Return on Assets (ttm)-26.70%
Return on Equity (ttm)-194.37%

Income Statement

Revenue (ttm)7.65M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)67.60%
Gross Profit (ttm)2.48M
EBITDA -71.64M
Net Income Avi to Common (ttm)-85.16M
Diluted EPS (ttm)-1.57
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)121.92M
Total Cash Per Share (mrq)2.23
Total Debt (mrq)131.32M
Total Debt/Equity (mrq)1,284.96
Current Ratio (mrq)21.93
Book Value Per Share (mrq)0.19

Cash Flow Statement

Operating Cash Flow (ttm)-65.25M
Levered Free Cash Flow (ttm)-31.73M